givinostat and panobinostat share 11 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.647 means 65% of the combined target set is bound by both compounds. The IDF-weighted score of 0.553 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do givinostat and panobinostat have in common?
givinostat and panobinostat share 11 molecular targets with a Jaccard similarity of 65%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can givinostat and panobinostat be combined?
givinostat and panobinostat share 11 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: givinostat or panobinostat?
Both givinostat and panobinostat have substantial PubMed research. View their individual profiles for full evidence scores.